Axios @axios
JUST IN: AstraZeneca acknowledged that a press release about its U.S. vaccine trial was based on data through Feb. 17, and promised to release more complete results that are "consistent with" the interim data within the next 48 hours. https://t.co/lgoeXqjNHf — PolitiTweet.org